Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11362)
All Articles published online
|
Publishing Process of This Article
|
Sep 28, 2014 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dongiovanni P, Romeo S, Valenti L. Hepatocellular carcinoma in nonalcoholic fatty liver: Role of environmental and genetic factors. World J Gastroenterol 2014; 20(36): 12945-12955 [PMID: 25278690 DOI: 10.3748/wjg.v20.i36.12945] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i36/12945.htm |
| Number | Citing Articles |
| 1 |
Claudia Campani, Carolina Bensi, Stefano Milani, Andrea Galli, Mirko Tarocchi. <p>Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes</p>. Journal of Hepatocellular Carcinoma 2020; : 107 doi: 10.2147/JHC.S252506
|
| 2 |
Hiroyasu Sakai, Yohei Shirakami, Masahito Shimizu. Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents. World Journal of Gastroenterology 2016; 22(1): 394-406 doi: 10.3748/wjg.v22.i1.394
|
| 3 |
Marica Meroni, Miriam Longo, Alice Rustichelli, Paola Dongiovanni. Nutrition and Genetics in NAFLD: The Perfect Binomium. International Journal of Molecular Sciences 2020; 21(8): 2986 doi: 10.3390/ijms21082986
|
| 4 |
Xing-Hui Li, Qi Liang, Tian-Wu Chen, Jian Wang, Xiao-Ming Zhang. Diagnostic value of imaging examinations in patients with primary hepatocellular carcinoma. World Journal of Clinical Cases 2018; 6(9): 242-248 doi: 10.12998/wjcc.v6.i9.242
|
| 5 |
Ken M. Chin, Mikel Prieto, Chin K. Cheong, Marcello Di Martino, Benedetto Ielpo, Brian K.P. Goh, Ye X. Koh. Outcomes after curative therapy for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: a meta-analysis and review of current literature. HPB 2021; 23(8): 1164 doi: 10.1016/j.hpb.2021.01.009
|
| 6 |
Mai Abd el-Meguid, Reham M. Dawood, Mohamed Aly Mokhles, Mostafa K. El Awady. Extrahepatic Upregulation of Transforming Growth Factor Beta 2 in HCV Genotype 4-Induced Liver Fibrosis. Journal of Interferon & Cytokine Research 2018; 38(8): 341 doi: 10.1089/jir.2018.0045
|
| 7 |
Paola Dongiovanni, Marica Meroni, Salvatore Petta, Miriam Longo, Anna Alisi, Giorgio Soardo, Luca Valenti, Luca Miele, Stefania Grimaudo, Grazia Pennisi, Grieco Antonio, Dario Consonni, Silvia Fargion, Anna Ludovica Fracanzani. Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLD. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020; 1865(10): 158765 doi: 10.1016/j.bbalip.2020.158765
|
| 8 |
Aftab Ullah, Gang Chen, Zhang Yibang, Abid Hussain, Muhammad Shafiq, Faisal Raza, Daojun Liu, Kaikai Wang, Jin Cao, Xueyong Qi. A new approach based on CXCR4-targeted combination liposomes for the treatment of liver fibrosis. Biomaterials Science 2022; 10(10): 2650 doi: 10.1039/D2BM00242F
|
| 9 |
Bum Hoi Kim. The Protective Effects of Silbi-um Extract on the Alcoholic Liver Injury in Rats. Journal of Korean Medicine for Obesity Research 2018; 18(2): 74 doi: 10.15429/jkomor.2018.18.2.74
|
| 10 |
Benedetta Donati, Luca Valenti. Telomeres, NAFLD and Chronic Liver Disease. International Journal of Molecular Sciences 2016; 17(3): 383 doi: 10.3390/ijms17030383
|
| 11 |
Liyun Xu, Wen Liu, Fuxiang Bai, Yong Xu, Xiaohong Liang, Chunhong Ma, Lifen Gao. Hepatic Macrophage as a Key Player in Fatty Liver Disease. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.708978
|
| 12 |
Chiara Saponaro, Melania Gaggini, Fabrizia Carli, Amalia Gastaldelli. The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis. Nutrients 2015; 7(11): 9453 doi: 10.3390/nu7115475
|
| 13 |
Ana Santos, Ana Santos, Clara Castro, Luís Raposo, Sofia Pereira, Isabel Torres, Rui Henrique, Helena Cardoso, Mariana Monteiro. Visceral Obesity and Metabolic Syndrome Are Associated with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors. Cancers 2018; 10(9): 293 doi: 10.3390/cancers10090293
|
| 14 |
Riccardo Nevola, Rachele Ruocco, Livio Criscuolo, Angela Villani, Maria Alfano, Domenico Beccia, Simona Imbriani, Ernesto Claar, Domenico Cozzolino, Ferdinando Carlo Sasso, Aldo Marrone, Luigi Elio Adinolfi, Luca Rinaldi. Predictors of early and late hepatocellular carcinoma recurrence. World Journal of Gastroenterology 2023; 29(8): 1243-1260 doi: 10.3748/wjg.v29.i8.1243
|
| 15 |
Federica Tavaglione, Giovanni Targher, Luca Valenti, Stefano Romeo. Human and molecular genetics shed lights on fatty liver disease and diabetes conundrum. Endocrinology, Diabetes & Metabolism 2020; 3(4) doi: 10.1002/edm2.179
|
| 16 |
Luca Valenti, Elisabetta Bugianesi, Utpal Pajvani, Giovanni Targher. Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?. Liver International 2016; 36(11): 1563 doi: 10.1111/liv.13185
|
| 17 |
Xian Zhang, Yi Zhou, Xueqing Yu, Qin Huang, Wenqian Fang, Jie Li, Joseph V. Bonventre, Galina K. Sukhova, Peter Libby, Guo-Ping Shi. Differential Roles of Cysteinyl Cathepsins in TGF-β Signaling and Tissue Fibrosis. iScience 2019; 19: 607 doi: 10.1016/j.isci.2019.08.014
|
| 18 |
Radhika Tippani, Sirisha Kalam, Srinivas Podeti, Mahendar Porika. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 181 doi: 10.1016/B978-0-323-98806-3.00019-2
|
| 19 |
Ali A. Mencin, Rohit Loomba, Joel E. Lavine. Caring for children with NAFLD and navigating their care into adulthood. Nature Reviews Gastroenterology & Hepatology 2015; 12(11): 617 doi: 10.1038/nrgastro.2015.146
|
| 20 |
Mehmet Serindere, Hatice Tuba Sanal, Mutlu Saglam, Cumhur Artuk, Kadir Ozturk, Omer Kurt. Comparison of the fibrosis degree using acoustic radiation force impulse elastography and diffusion-weighted magnetic resonance imaging in chronic hepatitis cases. Revista da Associação Médica Brasileira 2023; 69(8) doi: 10.1590/1806-9282.20221723
|
| 21 |
Min-Sun Kwak, Donghee Kim. Long-Term Outcomes of Nonalcoholic Fatty Liver Disease. Current Hepatology Reports 2015; 14(2): 69 doi: 10.1007/s11901-015-0258-6
|
| 22 |
Marcin Krawczyk, Monika Rau, Jörn M. Schattenberg, Heike Bantel, Anita Pathil, Münevver Demir, Johannes Kluwe, Tobias Boettler, Frank Lammert, Andreas Geier. Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study. Journal of Lipid Research 2017; 58(1): 247 doi: 10.1194/jlr.P067454
|
| 23 |
Jian-Ping Dou, Zhi-Yu Han, Fangyi Liu, Zhigang Cheng, Xiaoling Yu, Jie Yu, Ping Liang. Beneficial body mass index to enhance survival outcomes in patients with early-stage hepatocellular carcinoma following microwave ablation treatment. International Journal of Hyperthermia 2020; 37(1): 110 doi: 10.1080/02656736.2020.1712482
|
| 24 |
Simona Marchisello, Antonino Di Pino, Roberto Scicali, Francesca Urbano, Salvatore Piro, Francesco Purrello, Agata Maria Rabuazzo. Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview. International Journal of Molecular Sciences 2019; 20(8): 1948 doi: 10.3390/ijms20081948
|
| 25 |
Qinggang Tian, Yao Xiao, Yanting Wu, Yun Liu, Zhiqing Song, Wenfeng Gao, Jing Zhang, Jingling Yang, Yuguo Zhang, Tuankui Guo, Furong Dai, Zhigang Sun. MicroRNA-33b suppresses the proliferation and metastasis of hepatocellular carcinoma cells through the inhibition of Sal-like protein 4 expression. International Journal of Molecular Medicine 2016; 38(5): 1587 doi: 10.3892/ijmm.2016.2754
|
| 26 |
|
| 27 |
Eric Trépo, Stefano Romeo, Jessica Zucman-Rossi, Pierre Nahon. PNPLA3 gene in liver diseases. Journal of Hepatology 2016; 65(2): 399 doi: 10.1016/j.jhep.2016.03.011
|
| 28 |
Andrea Marengo, Chiara Rosso, Elisabetta Bugianesi. Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis. Annual Review of Medicine 2016; 67(1): 103 doi: 10.1146/annurev-med-090514-013832
|
| 29 |
Ana Cecilia Pontoriero, Julieta Trinks, María Laura Hulaniuk, Mariela Caputo, Lisandro Fortuny, Leandro Burgos Pratx, Analía Frías, Oscar Torres, Félix Nuñez, Adrián Gadano, Pablo Argibay, Daniel Corach, Diego Flichman. Influence of ethnicity on the distribution of genetic polymorphisms associated with risk of chronic liver disease in South American populations. BMC Genetics 2015; 16(1) doi: 10.1186/s12863-015-0255-3
|
| 30 |
Jiyu Ju, Lina Wang, Dalin Di, Weiling Xiao, Meiyu Peng, Yishuai Liu, Xiaoyan Fu, Chunling Zhao, Xuebin Qin. Adenovirus-mediated interleukin 21 gene transfer enhances antitumor immunity and reduces tumorigenicity of Hepa1–6 in mice. Oncology Letters 2016; 12(5): 3749 doi: 10.3892/ol.2016.5140
|
| 31 |
Nadia Panera, Marica Meroni, Miriam Longo, Annalisa Crudele, Luca Valenti, Emanuele Bellacchio, Luca Miele, Valentina D'Oria, Erika Paolini, Marco Maggioni, Anna Ludovica Fracanzani, Anna Alisi, Paola Dongiovanni. The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation. EBioMedicine 2021; 65: 103249 doi: 10.1016/j.ebiom.2021.103249
|
| 32 |
Ali A. Rabaan, Kizito Eneye Bello, Ahmad Adebayo Irekeola, Nawal A. Al Kaabi, Muhammad A. Halwani, Amjad A. Yousuf, Amer Alshengeti, Amal H. Alfaraj, Faryal Khamis, Maha F. Al-Subaie, Bashayer M. AlShehail, Souad A. Almuthree, Noha Y. Ibraheem, Mahassen H. Khalifa, Mubarak Alfaresi, Mona A. Al Fares, Mohammed Garout, Ahmed Alsayyah, Ahmad A. Alshehri, Ali S. Alqahtani, Mohammed Alissa. Prevalence of Hepatocellular Carcinoma in Hepatitis B Population within Southeast Asia: A Systematic Review and Meta-Analysis of 39,050 Participants. Pathogens 2023; 12(10): 1220 doi: 10.3390/pathogens12101220
|
| 33 |
Benedetta Donati, Paola Dongiovanni, Stefano Romeo, Marica Meroni, Misti McCain, Luca Miele, Salvatore Petta, Silvia Maier, Chiara Rosso, Laura De Luca, Ester Vanni, Stefania Grimaudo, Renato Romagnoli, Fabio Colli, Flaminia Ferri, Rosellina Margherita Mancina, Paula Iruzubieta, Antonio Craxi, Anna Ludovica Fracanzani, Antonio Grieco, Stefano Ginanni Corradini, Alessio Aghemo, Massimo Colombo, Giorgio Soardo, Elisabetta Bugianesi, Helen Reeves, Quentin M. Anstee, Silvia Fargion, Luca Valenti. MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-04991-0
|
| 34 |
Paola Dongiovanni, Luca Valenti. Genetics of nonalcoholic fatty liver disease. Metabolism 2016; 65(8): 1026 doi: 10.1016/j.metabol.2015.08.018
|
| 35 |
Sayaka Aizawa, Toru Okamoto, Yukari Sugiyama, Takahisa Kouwaki, Ayano Ito, Tatsuya Suzuki, Chikako Ono, Takasuke Fukuhara, Masahiro Yamamoto, Masayasu Okochi, Nobuhiko Hiraga, Michio Imamura, Kazuaki Chayama, Ryosuke Suzuki, Ikuo Shoji, Kohji Moriishi, Kyoji Moriya, Kazuhiko Koike, Yoshiharu Matsuura. TRC8-dependent degradation of hepatitis C virus immature core protein regulates viral propagation and pathogenesis. Nature Communications 2016; 7(1) doi: 10.1038/ncomms11379
|
| 36 |
Omar Massoud, Michael Charlton. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma. Clinics in Liver Disease 2018; 22(1): 201 doi: 10.1016/j.cld.2017.08.014
|
| 37 |
Min Yao, Wenjie Zheng, Li Wang, Miao Fang, Zhizhen Dong, Dengfu Yao. Neoplasm. 2018; doi: 10.5772/intechopen.77400
|
| 38 |
Benedetta Donati, Alessandro Pietrelli, Piero Pingitore, Paola Dongiovanni, Andrea Caddeo, Lucy Walker, Guido Baselli, Serena Pelusi, Chiara Rosso, Ester Vanni, Ann Daly, Rosellina Margherita Mancina, Antonio Grieco, Luca Miele, Stefania Grimaudo, Antonio Craxi, Salvatore Petta, Laura De Luca, Silvia Maier, Giorgio Soardo, Elisabetta Bugianesi, Fabio Colli, Renato Romagnoli, Quentin M. Anstee, Helen L. Reeves, Anna Ludovica Fracanzani, Silvia Fargion, Stefano Romeo, Luca Valenti. Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease. Cancer Medicine 2017; 6(8): 1930 doi: 10.1002/cam4.1078
|
| 39 |
Krasimira Aleksandrova, Marta Stelmach-Mardas, Sabrina Schlesinger. Obesity and Cancer. Recent Results in Cancer Research 2016; 208: 177 doi: 10.1007/978-3-319-42542-9_10
|
| 40 |
Francesca Giunchi, Francesco Vasuri, Michelangelo Fiorentino. Pathology and Epidemiology of Cancer. 2017; : 447 doi: 10.1007/978-3-319-35153-7_23
|
| 41 |
Misato Nakamura, Ayumi Eguchi, Mari Inohana, Rei Nagahara, Hirotada Murayama, Masashi Kawashima, Sayaka Mizukami, Mihoko Koyanagi, Shim-mo Hayashi, Robert R. Maronpot, Makoto Shibutani, Toshinori Yoshida. Differential impacts of mineralocorticoid receptor antagonist potassium canrenoate on liver and renal changes in high fat diet-mediated early hepatocarcinogenesis model rats. The Journal of Toxicological Sciences 2018; 43(10): 611 doi: 10.2131/jts.43.611
|
| 42 |
Justin T. Huntington, Xing Tang, Lindsey N. Kent, Carl R. Schmidt, Gustavo Leone. The Spectrum of E2F in Liver Disease-Mediated Regulation in Biology and Cancer. Journal of Cellular Physiology 2016; 231(7): 1438 doi: 10.1002/jcp.25242
|
| 43 |
Shanshan Liu, Yu Sun, Ming Jiang, Yangkai Li, Ye Tian, Weili Xue, Ninghe Ding, Yue Sun, Cheng Cheng, Jianshuang Li, Xiaoping Miao, Xinran Liu, Ling Zheng, Kun Huang. Glyceraldehyde‐3‐phosphate dehydrogenase promotes liver tumorigenesis by modulating phosphoglycerate dehydrogenase. Hepatology 2017; 66(2): 631 doi: 10.1002/hep.29202
|
| 44 |
Evangelia Makri, Antonis Goulas, Stergios A. Polyzos. Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease. Archives of Medical Research 2021; 52(1): 25 doi: 10.1016/j.arcmed.2020.11.010
|
| 45 |
Jinhang Zhu, Di Zhang, Ting Wang, Zhiliang Chen, Luan Chen, Hao Wu, Cong Huai, Jing Sun, Na Zhang, Muyun Wei, Fei Hong, Shengying Qin. Target identification of hepatic fibrosis using Pien Tze Huang based on mRNA and lncRNA. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-96459-5
|
| 46 |
Sunday Amos Onikanni, Bashir Lawal, Oluwafemi Shittu Bakare, Basiru Olaitan Ajiboye, Oluwafemi Adeleke Ojo, Abdullah Farasani, Saeed M Kabrah, Gaber El-Saber Batiha, Carlos Adam Conte-Junior. Cancer of the Liver and its Relationship with Diabetes mellitus. Technology in Cancer Research & Treatment 2022; 21: 153303382211197 doi: 10.1177/15330338221119743
|
| 47 |
Letiția Adela Maria Streba, Cristin Constantin Vere, Ion Rogoveanu, Costin Teodor Streba. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open question. World Journal of Gastroenterology 2015; 21(14): 4103-4110 doi: 10.3748/wjg.v21.i14.4103
|
| 48 |
Heidi Coia, Ning Ma, Yanqi Hou, Marcin D. Dyba, Ying Fu, M. Idalia Cruz, Carlos Benitez, Garrett T. Graham, Justine N. McCutcheon, Yun-Ling Zheng, Bing Sun, Bhaskar V. Kallakury, Junfeng Ma, Hong-Bin Fang, Deborah L. Berry, Vinona Muralidaran, Fung-Lung Chung. Prevention of Lipid Peroxidation–derived Cyclic DNA Adduct and Mutation in High-Fat Diet–induced Hepatocarcinogenesis by Theaphenon E. Cancer Prevention Research 2018; 11(10): 665 doi: 10.1158/1940-6207.CAPR-18-0160
|
| 49 |
Peter R. Galle, Alejandro Forner, Josep M. Llovet, Vincenzo Mazzaferro, Fabio Piscaglia, Jean-Luc Raoul, Peter Schirmacher, Valérie Vilgrain. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. Journal of Hepatology 2018; 69(1): 182 doi: 10.1016/j.jhep.2018.03.019
|
| 50 |
_ _, Oszkár Hahn, Attila Szijártó, Damján Pekli, András Fülöp, Bálint Kokas, Dávid Bárdos, Csilla András, Péter Bartek, István Battyáni, János Bezsilla, György Bodoky, Attila Bursics, Magdolna Dank, Zsófia Dankovics, Ákos Deák Pál, Kristóf Dede, Gyula Demeter, Attila Doros, Ibolyka Dudás, Zsófia Egyed, Róbert Farkas, Zsuzsanna Gerlei, Tamás Györke, Krisztina Hagymási, Oszkár Hahn, Erika Hitre, József Hőhn, Viktor Jancsik, Zsolt Káposztás, István Király, András Kiss, László Kóbori, Péter Kupcsulik, Gábor Lakatos, István Lázár, Tamás Lóderer, Endre Nagy, Attila Oláh, Péter Pajor, András Papp, Gabriella Pár, Mihály Patyánik, Damján Pekli, Ágota Petrányi, András Petri, László Piros, János Schuller, László Sikorszki, József Szabó, Eszter Székely, Attila Szijártó, Andrea Szombati, László Torday, Judit Tóth, Lajos Barna Tóth, Edit Dósa, László Harsányi, Zsolt Horváth, Gábor István, László Landherr, György Lázár, Gabriella Lengyel, József Lővey, László Mangel, Pál Maurovich Horváth, Balázs Nemes, András Palkó, Zsuzsa Schaff, Ferenc Szalay, Ákos Szűcs, András Vereczkei. A hepatocellularis carcinoma komplex kezelése.. Orvosi Hetilap 2022; 162(Supplement-2): 2 doi: 10.1556/650.2021.32431
|
| 51 |
George Cholankeril, Ronak Patel, Sandeep Khurana, Sanjaya K Satapathy. Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management. World Journal of Hepatology 2017; 9(11): 533-543 doi: 10.4254/wjh.v9.i11.533
|
| 52 |
Mahmoud Hussein Hassan Ali, Basim Anwar Shehata Messiha, Hekma Abdel-Tawab Abdel-Latif. Protective effect of ursodeoxycholic acid, resveratrol, andN-acetylcysteine on nonalcoholic fatty liver disease in rats. Pharmaceutical Biology 2015; : 1 doi: 10.3109/13880209.2015.1060247
|
| 53 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 2931 doi: 10.1007/978-3-319-26956-6_164
|
| 54 |
Pradeep Madhamanchi, Kishore Madhamanchi, Sujatha Peela, Panchareddy Madhava Rao, Pallaval Veera Bramhachari, Prakash Babu Panithi. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 255 doi: 10.1016/B978-0-323-98807-0.00021-1
|
| 55 |
Mariana Nikolova-Karakashian. Sphingolipids in Cancer. Advances in Cancer Research 2018; 140: 155 doi: 10.1016/bs.acr.2018.05.002
|
| 56 |
Antonella Cammarota, Antonio D’Alessio, Tiziana Pressiani, Lorenza Rimassa, Nicola Personeni. Systemic Treatment for Older Patients with Unresectable Hepatocellular Carcinoma. Drugs & Aging 2021; 38(7): 579 doi: 10.1007/s40266-021-00871-5
|
| 57 |
Ji Ye Lim, Chun Liu, Kang‐Quan Hu, Donald E. Smith, Dayong Wu, Stefania Lamon‐Fava, Lynne M. Ausman, Xiang‐Dong Wang. Xanthophyll β‐Cryptoxanthin Inhibits Highly Refined Carbohydrate Diet–Promoted Hepatocellular Carcinoma Progression in Mice. Molecular Nutrition & Food Research 2020; 64(3) doi: 10.1002/mnfr.201900949
|
| 58 |
Wanpeng Lu, Jinyu Mei, Juan Yang, Zhihan Wu, Jiayuan Liu, Pengyu Miao, Yiliang Chen, Zhenfan Wen, Zhongting Zhao, Hua Kong, Chao Wu, Yan Yang, Ming Chen. ApoE deficiency promotes non-alcoholic fatty liver disease in mice via impeding AMPK/mTOR mediated autophagy. Life Sciences 2020; 252: 117601 doi: 10.1016/j.lfs.2020.117601
|
| 59 |
Mani Sharma, Neeraj Kumar Chouhan, Sandeep Vaidya. Liver Pathology. 2021; doi: 10.5772/intechopen.92083
|
| 60 |
Giammauro Berardi, Alessandro Cucchetti, Carlo Sposito, Francesca Ratti, Martina Nebbia, Daniel M. D’Souza, Franco Pascual, Epameinondas Dogeas, Samer Tohme, Alessandro Vitale, Francesco D’Amico, Remo Alessandris, Valentina Panetta, Ilaria Simonelli, Marco Colasanti, Nadia Russolillo, Amika Moro, Guido Fiorentini, Matteo Serenari, Fernando Rotellar, Giuseppe Zimitti, Simone Famularo, Tommy Ivanics, Felipe Gaviria Donando, Daniel Hoffman, Edwin Onkendi, Yasmin Essaji, Tommaso Giuliani, Santiago Lopez Ben, Celia Caula, Gianluca Rompianesi, Asmita Chopra, Mohammed Abu Hilal, Gonzalo Sapisochin, Guido Torzilli, Carlos Corvera, Adnan Alseidi, Scott Helton, Roberto I. Troisi, Kerri Simo, Claudius Conrad, Matteo Cescon, Sean Cleary, Choon Hyuck David Kwon, Alessandro Ferrero, Giuseppe Maria Ettorre, Umberto Cillo, David Geller, Daniel Cherqui, Pablo E. Serrano, Cristina Ferrone, Luca Aldrighetti, T. Peter Kingham, Vincenzo Mazzaferro. Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndrome. JHEP Reports 2024; : 101075 doi: 10.1016/j.jhepr.2024.101075
|
| 61 |
Vivek Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, Pankti Balar, Avinash Khadela, Dixa Vaghela, Shruti Soni, Charles R. Ashby, Amit K. Tiwari. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes. Cancer Reports 2023; 6(S1) doi: 10.1002/cnr2.1821
|
| 62 |
Paola Berenice Mass Sanchez, Marinela Krizanac, Ralf Weiskirchen, Anastasia Asimakopoulos. Understanding the Role of Perilipin 5 in Non-Alcoholic Fatty Liver Disease and Its Role in Hepatocellular Carcinoma: A Review of Novel Insights. International Journal of Molecular Sciences 2021; 22(10): 5284 doi: 10.3390/ijms22105284
|
| 63 |
Trevor W Reichman, George Therapondos, Maria-Stella Serrano, John Seal, Rachel Evers-Meltzer, Humberto Bohorquez, Ari Cohen, Ian Carmody, Emily Ahmed, David Bruce, George E Loss. “Weighing the risk”: Obesity and outcomes following liver transplantation. World Journal of Hepatology 2015; 7(11): 1484-1493 doi: 10.4254/wjh.v7.i11.1484
|
| 64 |
Paola Dongiovanni, Raffaela Rametta, Marica Meroni, Luca Valenti. The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development – a potential therapeutic target?. Expert Review of Gastroenterology & Hepatology 2016; 10(2): 229 doi: 10.1586/17474124.2016.1110018
|
| 65 |
Soňa Fraňková, Jan Šperl. Rizikové faktory a surveillance hepatocelulárního karcinomu. Vnitřní lékařství 2019; 65(9): 583 doi: 10.36290/vnl.2019.100
|
| 66 |
Florian van Bömmel, Timm Denecke, Daniel Seehofer, Aaron Schindler, Rhea Veelken, Thomas Berg. Diagnostik und Therapie des hepatozellulären Karzinoms. Der Onkologe 2020; 26(12): 1175 doi: 10.1007/s00761-020-00858-8
|
| 67 |
Marica Meroni, Miriam Longo, Giada Tria, Paola Dongiovanni. Genetics Is of the Essence to Face NAFLD. Biomedicines 2021; 9(10): 1359 doi: 10.3390/biomedicines9101359
|
| 68 |
Rosa Lombardi, Roberto Piciotti, Paola Dongiovanni, Marica Meroni, Silvia Fargion, Anna Ludovica Fracanzani. PD-1/PD-L1 Immuno-Mediated Therapy in NAFLD: Advantages and Obstacles in the Treatment of Advanced Disease. International Journal of Molecular Sciences 2022; 23(5): 2707 doi: 10.3390/ijms23052707
|
| 69 |
Subrat K. Acharya, Sawan Bopanna. Hepatocellular Carcinoma Screening and Nonalcoholic Fatty Liver Disease: How is it Different?. Journal of Clinical and Experimental Hepatology 2020; 10(5): 518 doi: 10.1016/j.jceh.2020.04.004
|
| 70 |
Fengyun Xu, Changwei Liu, Dandan Zhou, Lei Zhang. TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis. Journal of Histochemistry & Cytochemistry 2016; 64(3): 157 doi: 10.1369/0022155415627681
|
| 71 |
Yongyuan He, Yinghong Su, Chengcheng Duan, Siyuan Wang, Wei He, Yingting Zhang, Xiaofei An, Ming He. Emerging role of aging in the progression of NAFLD to HCC. Ageing Research Reviews 2023; 84: 101833 doi: 10.1016/j.arr.2022.101833
|
| 72 |
Elizabeth P. Newberry, Zoe Hall, Yan Xie, Elizabeth A. Molitor, Peter O. Bayguinov, Gregory W. Strout, James A.J. Fitzpatrick, Elizabeth M. Brunt, Julian L. Griffin, Nicholas O. Davidson. Liver‐Specific Deletion of Mouse Tm6sf2 Promotes Steatosis, Fibrosis, and Hepatocellular Cancer. Hepatology 2021; 74(3): 1203 doi: 10.1002/hep.31771
|
| 73 |
Edmondo Falleti, Annarosa Cussigh, Sara Cmet, Carlo Fabris, Pierluigi Toniutto. PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis. Digestive and Liver Disease 2016; 48(1): 69 doi: 10.1016/j.dld.2015.09.009
|
| 74 |
Marica Meroni, Miriam Longo, Paola Dongiovanni. Genetic and metabolic factors: the perfect combination to treat metabolic associated fatty liver disease. Exploration of Medicine 2020; 1(4): 218 doi: 10.37349/emed.2020.00015
|
| 75 |
Mei Li, Frederik T. Larsen, Marius C. van den Heuvel, Konstanze Gier, Alan R. Gorter, Dorenda Oosterhuis, Johan Bijzet, Vincent E. de Meijer, Kim Ravnskjaer, Anika Nagelkerke, Peter Olinga. Metabolic Dysfunction-Associated Steatotic Liver Disease in a Dish: Human Precision-Cut Liver Slices as a Platform for Drug Screening and Interventions. Nutrients 2024; 16(5): 626 doi: 10.3390/nu16050626
|
| 76 |
Serena Pelusi, Guido Baselli, Alessandro Pietrelli, Paola Dongiovanni, Benedetta Donati, Misti Vanette McCain, Marica Meroni, Anna Ludovica Fracanzani, Renato Romagnoli, Salvatore Petta, Antonio Grieco, Luca Miele, Giorgio Soardo, Elisabetta Bugianesi, Silvia Fargion, Alessio Aghemo, Roberta D’Ambrosio, Chao Xing, Stefano Romeo, Raffaele De Francesco, Helen Louise Reeves, Luca Vittorio Carlo Valenti. Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-39998-2
|
| 77 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_164-1
|
| 78 |
Luca Valenti, Serena Pelusi. Non-Alcoholic Fatty Liver Disease. 2020; : 129 doi: 10.1007/978-3-319-95828-6_7
|
| 79 |
Rafiqatul Khairi, Zuherman Rustam, Suarsih Utama. Possibilistics C-Means (PCM) Algorithm for the Hepatocellular Carcinoma (HCC) Classification. IOP Conference Series: Materials Science and Engineering 2019; 546(5): 052038 doi: 10.1088/1757-899X/546/5/052038
|
| 80 |
Ahmet Uygun. Is That Possible to Stop or Cease the NASH to Turn into HCC?. Journal of Gastrointestinal Cancer 2017; 48(3): 250 doi: 10.1007/s12029-017-9961-6
|
| 81 |
Daniel Toman, Ilker Sengul, Anton Pelikán, Demet Sengul, Petr Vavra, Peter Ihnát, Jan Roman, Cuneyt Kayaalp. Hepatocellular carcinoma versus nonalcoholic fatty liver disease: metabolic, environmental, and genetic association? De facto?. Revista da Associação Médica Brasileira 2022; 68(5): 708 doi: 10.1590/1806-9282.20220147
|
| 82 |
Nádia Duarte, Inês C. Coelho, Rita S. Patarrão, Joana I. Almeida, Carlos Penha-Gonçalves, M. Paula Macedo. How Inflammation Impinges on NAFLD: A Role for Kupffer Cells. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/984578
|
| 83 |
Pegah Golabi, Logan Rhea, Linda Henry, Zobair M. Younossi. Hepatocellular carcinoma and non-alcoholic fatty liver disease. Hepatology International 2019; 13(6): 688 doi: 10.1007/s12072-019-09995-8
|
| 84 |
Omar Ramos-Lopez, Jose I. Riezu-Boj, Fermin I. Milagro, J. Alfredo Martinez. Association of Methylation Signatures at Hepatocellular Carcinoma Pathway Genes with Adiposity and Insulin Resistance Phenotypes. Nutrition and Cancer 2019; 71(5): 840 doi: 10.1080/01635581.2018.1531136
|
| 85 |
Yuji Ogawa, Masato Yoneda, Takashi Kobayashi, Yasushi Honda, Takaomi Kessoku, Kento Imajo, Satoru Saito, Atsushi Nakajima. Present and emerging pharmacotherapies for non-alcoholic steatohepatitis in adults. Expert Opinion on Pharmacotherapy 2019; 20(1): 69 doi: 10.1080/14656566.2018.1543403
|
| 86 |
Ramy Younes, Elisabetta Bugianesi. Should we undertake surveillance for HCC in patients with NAFLD?. Journal of Hepatology 2018; 68(2): 326 doi: 10.1016/j.jhep.2017.10.006
|
| 87 |
Paolo Gallo, Marianna Silletta, Federica Lo Prinzi, Tommaso Farolfi, Alessandro Coppola. Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Modern Context for an Ancient Disease. Journal of Clinical Medicine 2023; 12(14): 4605 doi: 10.3390/jcm12144605
|
| 88 |
Mehmet Sayiner, Zobair M Younossi. Identifying patients at risk from nonalcoholic fatty liver-related hepatocellular carcinomas. Hepatic Oncology 2016; 3(2): 101 doi: 10.2217/hep-2016-0002
|
| 89 |
Bakhovuddin Azamov, Kwang-Min Lee, Jin Hur, Shakhnoza Muradillaeva, Wan-Seog Shim, Chanhee Lee, Parkyong Song. Oxoglaucine Suppresses Hepatic Fibrosis by Inhibiting TGFβ-Induced Smad2 Phosphorylation and ROS Generation. Molecules 2023; 28(13): 4971 doi: 10.3390/molecules28134971
|
| 90 |
Patricia E. Ganey, Sean A. Misek. Cellular Signal Transduction in Toxicology and Pharmacology. 2019; : 73 doi: 10.1002/9781119060208.ch4
|
| 91 |
Aakash Desai, Sonia Sandhu, Jin-Ping Lai, Dalbir Singh Sandhu. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review. World Journal of Hepatology 2019; 11(1): 1-18 doi: 10.4254/wjh.v11.i1.1
|
| 92 |
Mark A. Febbraio, Saskia Reibe, Shabnam Shalapour, Geraldine J. Ooi, Matthew J. Watt, Michael Karin. Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?. Cell Metabolism 2019; 29(1): 18 doi: 10.1016/j.cmet.2018.10.012
|
| 93 |
Paola Dongiovanni, Marica Meroni, Miriam Longo, Silvia Fargion, Anna Fracanzani. miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis. International Journal of Molecular Sciences 2018; 19(12): 3966 doi: 10.3390/ijms19123966
|
| 94 |
Maki Tobari, Etsuko Hashimoto, Makiko Taniai, Takayoshi Nishino, Katsutoshi Tokushige. Hepatocellular carcinoma in young morbid obese patients with non-alcoholic fatty liver disease. Clinical Journal of Gastroenterology 2020; 13(6): 1289 doi: 10.1007/s12328-020-01215-3
|
| 95 |
Helma P. Cotrim, Claudia P. Oliveira, Henrique Sérgio M. Coelho, Mario R. Alvares-da-Silva, Leticia Nabuco, Edison Roberto Parise, Claúdia Ivantes, Ana LC Martinelli, João Galizzi-Filho, Flair J. Carrilho. Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey. Clinics 2016; 71(5): 281 doi: 10.6061/clinics/2016(05)07
|
| 96 |
Matthew Schade, Jacqueline A Sanabria, Milad Modarresi, Bryan Gillon, Zach Hunter, Jacqueline Fannin, Amrita Mallick, Henri Brunengraber, Juan Sanabria. Hepatocellular Carcinoma - Advances in Diagnosis and Treatment. 2018; doi: 10.5772/intechopen.71659
|
| 97 |
Jin Yan, Zijia Zhao, Min Xia, Shuya Chen, Xiancheng Wan, Anfei He, Guangyao Daniel Sheng, Xuedong Wang, Qiuhui Qian, Huili Wang. Induction of lipid metabolism dysfunction, oxidative stress and inflammation response by tris(1-chloro-2-propyl)phosphate in larval/adult zebrafish. Environment International 2022; 160: 107081 doi: 10.1016/j.envint.2022.107081
|
| 98 |
Sukeshi Patel Arora, Gabor Liposits, Susan Caird, Richard F. Dunne, Gordon Taylor Moffat, David Okonji, Maria Grazia Rodriquenz, Divyanshu Dua, Efrat Dotan. Hepatocellular carcinoma in older adults: A comprehensive review by Young International Society of Geriatric Oncology. Journal of Geriatric Oncology 2020; 11(4): 557 doi: 10.1016/j.jgo.2019.10.007
|
| 99 |
Lisa P Waller, Vrushak Deshpande, Nikolaos Pyrsopoulos. Hepatocellular carcinoma: A comprehensive review. World Journal of Hepatology 2015; 7(26): 2648-2663 doi: 10.4254/wjh.v7.i26.2648
|
| 100 |
Matthew J. Sarna, Marcoandrea Giorgi. The Link Between Obesity and Cancer. 2023; : 155 doi: 10.1016/B978-0-323-90965-5.00002-7
|
| 101 |
Marten Schulz, Frank Tacke. <p>Identifying High-Risk NASH Patients: What We Know so Far</p>. Hepatic Medicine: Evidence and Research 2020; : 125 doi: 10.2147/HMER.S265473
|